missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Epredia™ Lab Vision™ NY-BR-1 Mouse Monoclonal Antibody
Take advantage of a quality product that delivers accurate results with the Epredia™ NY-BR-1, Mouse Monoclonal Antibody.
Brand: Epredia™ MS-1932-RQ
This item is not returnable.
View return policy
Description
NY-BR-1 is a novel differentiation marker predominantly expressed in normal breast and breast cancer. It has been shown by Immunohistochemistry (IHC) that NY-BR-1 was present solely in ductal epithelium of normal breast tissue. Invasive carcinoma of the breast and carcinoma in situ were positive for NY-BR-1, whereas most other tumors and normal tissues are negative, with the exceptions of one-third of sweat gland carcinomas and around two percent of prostate carcinoma. NY-BR-1 is reported to express more frequently in estrogen-positive and lymph node-negative primary carcinomas, and more commonly in grade 1 than in grade 2 or grade 3. In a study by Varga et al (2006) forty-nine percent of lymph node metastasis were shown to be positive.Host Species: Mouse
Clone: NY-BR-1No. 2
Isotype: IgG1/κ
Species Reactivity: Human. Others not tested.
Epitope: Not determined
Immunogen: a 77 aa peptide from human NYBR-1 protein
Molecular Weight: 150-160kDa
Positive Control: Breast carcinoma
Cellular Localization: Predominantly cytoplasmic and occasional nuclear
Recommended for:
Immunohistochemistry (Formalin/paraffin)
Specifications
| NY-BR-1 | |
| NY-BR-1 No.2 | |
| Mouse | |
| 12 mL | |
| Ready-to-Use |
| Immunohistochemistry | |
| Unconjugated | |
| a 77 aa peptide from human NYBR-1 protein | |
| Primary |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction